What The Papers Say: Economic burden of inadequate management of allergic diseases in the European Union

In the European Union (EU) between 44 and 76 million individuals of the 217 million EU-employees suffer from allergic disease of the airways or the skin. Up to 90% of these persons are untreated or insufficiently treated. This has major socioeconomic consequences, in absence from work (absenteeism) but particularly in reduced productivity at work (presenteeism).

To read more about this article, please follow this link to the Wiley Online website.

See more eczema-related news headlines on What The Papers Say.